Jun Kawashima

Statistics

Publications

Citations

460

H-Index

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Mayo Clinic in Arizona

City Of Hope National Medical Center

Dana-Farber Cancer Institute

Jun Kawashima is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematologic malignancy therapy, and oncology.

ORCID

Publications per year

2012–2023

Publications

Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States

Caron A. Jacobson, Frederick L. Locke, Long Ma et al. · Transplantation and Cellular Therapy · 2022 · 181 citations · Full text

Medicine, Hematology, Oncology +13

Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)

Marcelo C. Pasquini, Frederick L. Locke, Alex F. Herrera et al. · Blood · 2019 · 95 citations

Medicine, Hematology, Oncology +15

Interim Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) as First-Line Therapy in Patients (Pts) With High-Risk Large B Cell Lymphoma (LBCL)

Sattva S. Neelapu, Michael Dickinson, Matthew L. Ulrickson et al. · Blood · 2020 · 44 citations

Medicine, Hematology, Oncology +15

A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia

Srđan Verstovšek, Stéphane Courby, Martin Grießhammer et al. · Leukemia Research · 2017 · 41 citations · Full text

Medicine, Hematology, Pharmacology +8

Delayed effects of single neonatal subcutaneous exposure of low-dose 17α-ethynylestradiol on reproductive function in female rats

Mariko Shiorta, Jun Kawashima, T. Nakamura et al. · The Journal of Toxicological Sciences · 2012 · 26 citations · Full text

Medicine, Endocrinology, Toxicology +17

1–5 of 11